Celaleddin SOYALP, Gokhan OTO, Erol KARAASLAN, İlhami BERBER, Muhammet Serdar BUĞDAY, Ersoy ÖKSÜZ, Rezzan TEMELLİ GÖÇEROĞLU

Drug-drug interactions in intensive care units and potential clinical consequences of these interactions

Aim: Drug-drug interactions (DDIs) are an important factor that can lead to serious health problems by increasing or decreasing theeffects of drugs. This study aimed to evaluate the frequency of DDIs in the intensive care unit (ICU).Material and Methods: All patients who were hospitalized for more than 24 h in the ICU of our hospital between January andSeptember 2018 and received 2 or more medications were included in this retrospective study. Frequency and severity of the DDIswere detected using the Rx Mediapharma and Lexi-Interact programs.Results: Of the 972 patients enrolled in the study, 2742 incidences of DDIs were detected in 626 patients (64%). Of the differentdrug pairs administered, 422 had DDIs, and 64 of those had 10 or more DDIs, constituting 67% of all of the DDIs. The most commonpotential clinical consequences of DDIs were increased risk of bleeding (12.3%), hyperkalemia (8.2%), arrhythmia (7.9%), and CNSdepression (6.6%).Conclusion: The results indicated that DDIs in the ICU were very common in our hospital. Moreover, these results indicated thatpatients should be closely monitored for the prevention of adverse effects, such as electrolyte disturbance, bleeding risk, andarrhythmia of drugs.

PDF

___

1. Gulcebi Idriz Oglu M, Kucukibrahimoglu E, Karaalp A, et al. Potential drug-drug interactions in a medical intensive care unit of a university hospital. Turk J Med Sci 2016;46:812-9.
2. Van Roon EN, Flikweert S, le Comte M, et al. Clinical relevance of drug-drug interactions : a structured assessment procedure. Drug safety 2005;28:1131-9.
3. Krahenbuhl-Melcher A, Schlienger R, Lampert M, et al. Drug-related problems in hospitals: a review of the recent literature. Drug safety 2007;30:379-407.
4. Guedon-Moreau L, Ducrocq D, Duc MF, et al. Absolute contraindications in relation to potential drug interactions in outpatient prescriptions: analysis of the first five million prescriptions in 1999. Eur J Clin Pharmacol 2003;59:689-95.
5. Kohler GI, Bode-Boger SM, Busse R, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. International journal of clinical pharmacology and therapeutics 2000;38:504-13.
6. Spriet I, Meersseman W, De Hoon J, et al. Mini-series: II. clinical aspects. clinically relevant CYP450-mediated drug interactions in the ICU. Intensive care medicine 2009;35:603-12.
7. Kopp BJ, Erstad BL, Allen ME, et al. Medication errors and adverse drug events in an intensive care unit: Direct observation approach for detection. Critical Care Medicine 2006;34:415-25.
8. Askari M, Eslami S, Louws M, et al. Frequency and nature of drug-drug interactions in the intensive care unit Pharmacoepidemiol. Drug Saf 2013;22:430-7.
9. Uijtendaal EV, van Harssel LL, Hugenholtz GW, et al.Analysis of potential drug-drug interactions in medical intensive care unit patients. Pharmacotherapy 2014;34:213-9.
10. Lima RE, De Bortoli Cassiani SH. Potential drug interactions in intensive care patients at a teaching hospital. Revista latino-americana de enfermagem 2009;17:222-7.
11. Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. Int J Pharm Pract 2012;20:402-8.
12. Smithburger PL, Kane-Gill SL, Seybert AL. Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US. Drug safety 2010;33:879-88.
13. Kuscu F, Ulu A, Inal AS, et al. Potential Drug-Drug Interactions with Antimicrobials in Hospitalized Patients: A Multicenter Point-Prevalence Study. Med Sci Monit 2018;24:4240-7.
14. Reimche L, Forster AJ, van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol 2011;51:1043-50.
15. Rodrigues AT, Stahlschmidt R, Granja S, et al. Clinical relevancy and risks of potential drug-drug interactions in intensive therapy. Saudi Pharm J 2015;23:366-70.
16. Zwart-van Rijkom JE, Uijtendaal EV, ten Berg MJ, et al. Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J Clin Pharmacol 2009;68:187-93.
17. Bjerrum L, Andersen M, Petersen G, et al. Exposure to potential drug interactions in primary health care. Scandinavian journal of primary health care 2003;21:153-8.
18. Hossein Ali Mehralian, Jafar Moghaddasi, Hossein Rafiei. The prevalence of potentially beneficial and harmful drugdrug interactions in intensive care units. Drug Metab Pers Ther 2019;34:1-7.